Literature DB >> 15282113

Acute ethanol exposure modulates expression of inducible nitric-oxide synthase in human astroglia: evidence for a transcriptional mechanism.

Randall L Davis1, Peter J Syapin.   

Abstract

Astroglia are important in immunocompetence and response to injury within the CNS. Activated astroglia respond, in part, by expressing inducible nitric-oxide synthase (iNOS) and subsequent catalytic production of nitric oxide. Results from a previous study in our laboratory, in the human A172 astroglial cell line, revealed that induction of iNOS activity by tumor necrosis factor-alpha + interferon-gamma + interleukin-1 beta was inhibited by 24-h exposure to a high ethanol concentration (200 mM), but enhanced by 50 mM ethanol. In the work reported in this article, we tested the working hypothesis that ethanol acts transcriptionally to modulate cytokine-induced expression of the iNOS gene, NOS2A, in human astroglia. Ethanol, 50 or 200 mM, did not directly alter in vitro catalytic activity of the iNOS enzyme, indicating that ethanol does not affect the enzyme directly. Likewise, ethanol exposure after a 12-h cytokine-stimulation period had no effect on in vivo iNOS activity. However, when cells were simultaneously exposed to ethanol and cytokines for 12 h, in vivo iNOS activity was altered. That ethanol must be present during cytokine stimulation to influence iNOS activity is consistent with a transcriptional mechanism of action. In addition, steady-state expression of iNOS protein and NOS2A mRNA levels were modulated in a biphasic manner by ethanol similar to that noted previously for iNOS activity. These findings strongly support the suggestion that ethanol modulates cytokine-induced iNOS expression in A172 cells at a pretranslational site. These findings should be instrumental in the identification of the critical ethanol-sensitive elements involved in the regulation of NOS2A in human astroglia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282113     DOI: 10.1016/j.alcohol.2004.01.006

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  7 in total

1.  SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.

Authors:  Maria Lauda Tomasi; Komal Ramani; Minjung Ryoo; Carla Cossu; Andrea Floris; Ben J Murray; Ainhoa Iglesias-Ara; Ylenia Spissu; Nirmala Mavila
Journal:  FASEB J       Date:  2018-01-18       Impact factor: 5.191

Review 2.  HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.

Authors:  Yuri Persidsky; Wenzhe Ho; Servio H Ramirez; Raghava Potula; Mary E Abood; Ellen Unterwald; Ronald Tuma
Journal:  Brain Behav Immun       Date:  2011-03-21       Impact factor: 7.217

3.  Commentary on the interactions of HIV and alcohol in the central nervous system.

Authors:  Madhavan P Nair; Marisela Agudelo
Journal:  Alcohol Clin Exp Res       Date:  2013-12-10       Impact factor: 3.455

4.  The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Craig W Stevens
Journal:  J Neuroimmunol       Date:  2007-05-01       Impact factor: 3.478

Review 5.  Ethanol metabolism and effects: nitric oxide and its interaction.

Authors:  Xin-Sheng Deng; Richard A Deitrich
Journal:  Curr Clin Pharmacol       Date:  2007-05

6.  Beta-funaltrexamine inhibits inducible nitric-oxide synthase expression in human astroglial cells.

Authors:  Randall L Davis; Daniel J Buck; Neda Saffarian; Shekher Mohan; Udaya DeSilva; Samodha C Fernando; Craig W Stevens
Journal:  J Neuroimmune Pharmacol       Date:  2008-02-16       Impact factor: 4.147

Review 7.  HIV-1 and alcohol: interactions in the central nervous system.

Authors:  Peter S Silverstein; Anil Kumar
Journal:  Alcohol Clin Exp Res       Date:  2013-10-17       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.